Groth, N.; Bruhwyler, J.; Tourneur, J.; Piat, E.; Moris, P.; Le Vert, A.; Nicolas, F.
Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix® Tetra, a Seasonal Hemagglutinin-Based Vaccine. Vaccines 2025, 13, 558.
https://doi.org/10.3390/vaccines13060558
AMA Style
Groth N, Bruhwyler J, Tourneur J, Piat E, Moris P, Le Vert A, Nicolas F.
Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix® Tetra, a Seasonal Hemagglutinin-Based Vaccine. Vaccines. 2025; 13(6):558.
https://doi.org/10.3390/vaccines13060558
Chicago/Turabian Style
Groth, Nicola, Jacques Bruhwyler, Jessika Tourneur, Emilie Piat, Philippe Moris, Alexandre Le Vert, and Florence Nicolas.
2025. "Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix® Tetra, a Seasonal Hemagglutinin-Based Vaccine" Vaccines 13, no. 6: 558.
https://doi.org/10.3390/vaccines13060558
APA Style
Groth, N., Bruhwyler, J., Tourneur, J., Piat, E., Moris, P., Le Vert, A., & Nicolas, F.
(2025). Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix® Tetra, a Seasonal Hemagglutinin-Based Vaccine. Vaccines, 13(6), 558.
https://doi.org/10.3390/vaccines13060558